slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 19,951-19,980
Pages 885
Rows per page 30
Arc
19,951-19,980 of 26,550
13
Clinical trial data presented at ASCO GI22.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
15
Clinical trial data presentation showing bar chart for ORR and Kaplan-Meier curve for DoR.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
18
The slide uses a process flow to illustrate clinical guidelines.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
19
BTC likely stands for Biliary Tract Cancer.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
20
This is a standard academic citation slide.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
21
Standard clinical trial CONSORT flow diagram.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
22
The slide includes a 'Number at risk' table below the chart, which is standard for clinical trial survival analysis.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
23
BTC stands for Biliary Tract Cancer. The slide contrasts established standard-of-care regimens with the lack of efficacy for taxanes.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
24
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
25
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
26
The slide uses red arrows for primary categories and blue arrows for sub-points.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
27
The plot displays individual patient responses categorized by cancer type (Gastric, CRC, Cholangio, Pancreatic, Other).Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
28
Includes footnotes explaining context for hypertension and cytopenia events compared to standard chemotherapy agents.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
29
Uses a Simon 2-stage adaptive design.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
30
Clinical trial update slide showing patient enrollment and efficacy metrics (PRs and ORR).Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
31
Includes a red highlight box around the '2 prior systemic therapies' row.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
32
Standard oncology waterfall plot showing individual patient response to treatment.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
33
The chart displays patient-level data including treatment duration, partial response (PR), stable disease (SD), progressive disease (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
34
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
35
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
36
The slide uses a bulleted list to present clinical trial data and competitive benchmarks.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
01
Features a network-style graphic representing complex data relationships.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
02
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
03
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
04
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
06
The slide uses a simple linear process flow to establish the baseline context for the presentation.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication1 hit
09
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Propose Solution1 hit
10
The diagram uses a central human silhouette to emphasize patient-centricity in the R&D lifecycle.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Propose Solution1 hit
11
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Evidence1 hit